| Bioactivity | C12 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C12 nitrobenzoxadiazole (C12 NBD) group. C12 NBD galactosylceramide has been used to detect ceramide trihexoside[1]. |
| Invitro | C12 NBD globotriaosylceramide accumulates in human umbilical vascular endothelial cells (HUVECs) treated with the α-galactosidase A inhibitor in a concentration-dependent manner[2]. |
| Name | C12 NBD Globotriaosylceramide |
| CAS | 2692623-26-8 |
| Formula | C54H91N5O21 |
| Molar Mass | 1146.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kassiani Kytidou, et al. Nicotiana benthamiana α-galactosidase A1.1 can functionally complement human α-galactosidase A deficiency associated with Fabry disease. J Biol Chem. 2018 Jun 29;293(26):10042-10058. [2]. Janet Hsu, et al. Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release. 2011 Feb 10;149(3):323-31. |
C12 NBD Globotriaosylceramide
CAS: 2692623-26-8 F: C54H91N5O21 W: 1146.32
C12 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.